Released Aug 14, 2014, after the close
10-Q filed Aug 14, 2014, 45 days after period end · 0001144204-14-050130
Q2 2014 · 10-Q
Revenue—
Net Income-$2.47M-$2.47M N/M vs Q2 2013N/M vs Q1 2014
EPS Diluted-$0.52-$0.52 N/M vs Q2 2013N/M vs Q1 2014
Operating Income-$2,506,144N/M
Operating Cash Flowderived-$2,320,394—
Free Cash Flowderived-$2,320,394—
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2014 | Q2 2013 | Q2 2012 | Q2 2011 |
|---|---|---|---|---|
| Net Income | -$2.47M | -$4.75M | -$7.47M | -$6.96M |
| EPS Diluted | -$0.52 | -$1.20 | -$0.59 | -$0.97 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR